Ittai Muller

MSC.

20162019
If you made any changes in Pure these will be visible here soon.

Research Output 2016 2019

Ontwikkeling van een LC-MS/MS methode voor de bepaling van folylpolyglutamaat synthetase (FPGS)

Muller, IB., Struys, EA., Lems, WF., Cloos, J., Jansen, G. & de Jonge, R., Oct 2018, In : Analyse. 73, 5, p. 101-103 3 p.

Research output: Contribution to journalArticleProfessional

2017

Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: Clinical impact of alectinib

Muller, I. B., De Langen, A. J., Giovannetti, E. & Peters, G. J., 13 Sep 2017, In : OncoTargets and Therapy. 10, p. 4535-4541 7 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: Clinical evidence and new pharmacological tools

Giovannetti, E., Zucali, P. A., Assaraf, Y. G., Funel, N., Gemelli, M., Stark, M., Thunnissen, E., Hou, Z., Muller, I. B., Struys, E. A., Perrino, M., Jansen, G., Matherly, L. H. & Peters, G. J., 2017, In : Annals of Oncology. 28, 11, p. 2725-2732 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

2016

Overcoming crizotinib resistance in ALK-rearranged NSCLC with the second-generation ALK-inhibitor ceritinib

Muller, I. B., De Langen, A. J., Honeywell, R. J., Giovannetti, E. & Peters, G. J., 1 Feb 2016, In : Expert Review of Anticancer Therapy. 16, 2, p. 147-157

Research output: Contribution to journalArticleAcademicpeer-review